Rhabdomyosarcoma overview

Revision as of 14:13, 10 September 2015 by Suveenkrishna Pothuru (talk | contribs)
Jump to navigation Jump to search

Rhabdomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rhabdomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rhabdomyosarcoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rhabdomyosarcoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rhabdomyosarcoma overview

CDC on Rhabdomyosarcoma overview

Rhabdomyosarcoma overview in the news

Blogs on Rhabdomyosarcoma overview

Directions to Hospitals Treating Rhabdomyosarcoma

Risk calculators and risk factors for Rhabdomyosarcoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

A rhabdomyosarcoma is a type of cancer, specifically a sarcoma (cancer of connective tissues), in which the cancer cells are thought to arise from skeletal muscle progenitors. It can also be found attached to muscle tissue, wrapped around intestines, or anywhere, to include the neck area. It is most common in children ages one to five, and teens aged 15 to 19, although quite rare in the latter. It can be a cardiac manifestation of tuberous sclerosis.

Rhabdomyosarcoma is a relatively rare form of cancer. Its two most common forms are embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma. In the former, which is more common in younger children, the cancer cells resemble those of a typical 6-to-8-week embryo. In the latter, which is more common in older children and teenagers, they resemble those of a typical 10-to-12-week embryo.

Classification

Rhabdomyosarcoma may be classified according to the "International classification of rhabdomyosarcoma" into six subtypes Alveolar rhabdomyosarcoma, embryonal rhabdomyosarcoma, botryoid rhabdomyosarcoma, spindle cell rhabdomyosarcoma, and undifferentiated rhabdomyosarcoma.

Pathophysiology

Rhabdomyosarcoma arises from the skeletal muscle cells. Development of rhabdomyosarcoma is result of specific genetic mutations. Genes involved in the pathogenesis of alveolar rhabdomyosarcoma include t(2;13) and t(1;13) chromosomal translocations. The microscopic pathology of rhabdomyosarcoma depends on the histological subtype.

Causes

There are no established causes for rhabdomyosarcoma.

Differential Diagnosis

Rhabdomyosarcoma of orbit must be differentiated from other causes of orbital masses such as orbital pseudotumor, orbital tumors, orbital abscess, and vascular lesions.

Epidemiology and Demographics

Rhabdomyosarcoma is a relatively rare form of cancer. It is most common soft tissue sarcoma in children. The overall incidence of rhabdomyosarcoma in children is approximately 0.45 cases per 100,000 children. Rhabdomyosarcoma tends to affect individuals <45 Years.

Risk Factors

The common risk factors in the development of rhabdomyosarcoma are Beckwith-Wiedemann syndrome, Li-Fraumeni syndrome, Costello syndrome, and Noonan syndrome.

Screening

Screening for rhabdomyosarcoma is not recommended.

Natural History, Complications and Prognosis

Common complication of rhabdomyosarcoma include metastasis to lung, bone marrow, and bone. Rhabdomyosarcoma is associated with a 5 year survival rate of 72%. The presence of metastasis is associated with a particularly poor prognosis. The embryonal type rhabdomyosarcoma is associated with the most favorable prognosis. Orbital and genitourinary tract rhabdomyosarcomas have the most favorable prognosis.

Diagnosis

Staging

According to the childrens oncology group, there are four stages of rhabdomyosarcoma based on the location of tumor, size of tumor, involvement of lymph nodes, and metastasis.

Physical Examination

Symptoms of rhabdomyosarcoma include a rapidly growing mass and pressure effects on neurovascular structures.

Laboratory Findings

An elevated concentration of skeletal muscle protein myo D1 is diagnostic of rhabdomyosarcoma.

CT

On CT scan rhabdomyosarcoma is characterized by soft tissue density, enhancement with contrast, and adjacent bone destruction.

MRI

On MRI rhabdomyosarcoma is characterized by low to intermediate intensity on T1, hyperintense on T2, and considerable contrast enhancement on T1 contrast.

References

Template:WH Template:WS